Amphastar Pharmaceuticals (AMPH)
(Delayed Data from NSDQ)
$40.41 USD
-1.16 (-2.79%)
Updated Aug 5, 2024 04:00 PM ET
After-Market: $40.42 +0.01 (0.02%) 4:44 PM ET
3-Hold of 5 3
A Value B Growth F Momentum A VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC8/7/24 |
---|---|
Current Quarter | 0.78 |
EPS Last Quarter | 1.04 |
Last EPS Surprise | 35.06% |
ABR | 1.57 |
Earnings ESP
|
-0.90% |
---|---|
Current Year | 3.80 |
Next Year | 4.45 |
EPS (TTM) | 3.72 |
P/E (F1) | 10.95 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 171.29M | 199.54M | 747.72M | 852.95M |
# of Estimates | 4 | 4 | 4 | 3 |
High Estimate | 177.06M | 215.91M | 773.67M | 874.30M |
Low Estimate | 166.70M | 185.40M | 723.90M | 834.54M |
Year ago Sales | 145.71M | 180.56M | 644.40M | 747.72M |
Year over Year Growth Est. | 17.55% | 10.51% | 16.03% | 14.07% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.78 | 0.98 | 3.80 | 4.45 |
# of Estimates | 5 | 4 | 5 | 4 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | 0.89 | 1.04 | 3.97 | 4.75 |
Low Estimate | 0.71 | 0.83 | 3.63 | 4.08 |
Year ago EPS | 0.65 | 1.15 | 3.32 | 3.80 |
Year over Year Growth Est. | 20.00% | -14.78% | 14.46% | 17.28% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 2 |
Up Last 60 Days | 0 | 0 | 0 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 2 | 0 | 2 | 0 |
Down Last 60 Days | 2 | 0 | 2 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.78 | 0.98 | 3.80 | 4.45 |
7 Days Ago | 0.78 | 0.98 | 3.80 | 4.45 |
30 Days Ago | 0.81 | 0.98 | 3.86 | 4.38 |
60 Days Ago | 0.81 | 0.98 | 3.86 | 4.38 |
90 Days Ago | 0.78 | 1.00 | 3.70 | 4.30 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.78 | 0.98 | 3.77 | 4.39 |
Zacks Consensus Estimate | 0.78 | 0.98 | 3.80 | 4.45 |
Earnings ESP | -0.90% | 0.00% | -0.82% | -1.40% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.04 | 0.88 | 1.15 | 0.65 | NA |
Estimate | 0.77 | 0.87 | 0.70 | 0.57 | NA |
Difference | 0.27 | 0.01 | 0.45 | 0.08 | 0.20 |
Surprise | 35.06% | 1.15% | 64.29% | 14.04% | 28.64% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more